[HSF] Fwd: STS MEMBER ALERT: FDA Issues Statement on Use
ofAprotinin (Tra...
Ben Bidstrup
benjamin.bidstrup at bigpond.com
Sun Oct 28 11:54:23 EDT 2007
>Claudia,
> It may be a "nice" drug, but it sure is getting an increasingly dangerous
>reputation. The FDA site is _http://www.fda.gov/cder/drug/early_
>(http://www.fda.gov/cder/drug/early) comm/aprotinin.htm. Members
>should know that I've
>got absolutely no financial interest one way or the other in regards to
>aprotinin. However, I believe its use should be limited to
>dialysis patients or
>patients undergoing major aortic reconstructions.
>
>Hal
>
Before one goes to town and draws conclusions, the details of the
reasons for stopping (approaching significance) and the analysis of
the data which will take 6-8 weeks must be awaited.
--
Ben Bidstrup FRACS FRCSEd FEBCTS
Consultant Cardiothoracic Surgeon
More information about the OpenHeart-L
mailing list